|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1998-3-2
|
|
pubmed:abstractText |
To assess whether granulocyte-macrophage colony-stimulating factor (GM-CSF) reduces the toxicity of chemotherapy and alters delivered dose-intensity. To assess the feasibility of dose-intensification of chemotherapy in small-cell lung cancer (SCLC) and determine whether it has an impact on outcome.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:ClancyLL,
pubmed-author:FennellyJJ,
pubmed-author:FrischJJ,
pubmed-author:GatzemeierUU,
pubmed-author:KoschelGG,
pubmed-author:PfeiferWW,
pubmed-author:StewardW PWP,
pubmed-author:ThatcherNN,
pubmed-author:VerweijJJ,
pubmed-author:WolfZZ,
pubmed-author:de WitRR,
pubmed-author:von EiffMM,
pubmed-author:von PawelJJ
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
16
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
642-50
|
|
pubmed:dateRevised |
2006-4-24
|
|
pubmed:meshHeading |
pubmed-meshheading:9469353-Adult,
pubmed-meshheading:9469353-Aged,
pubmed-meshheading:9469353-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:9469353-Carboplatin,
pubmed-meshheading:9469353-Carcinoma, Small Cell,
pubmed-meshheading:9469353-Double-Blind Method,
pubmed-meshheading:9469353-Etoposide,
pubmed-meshheading:9469353-Female,
pubmed-meshheading:9469353-Granulocyte-Macrophage Colony-Stimulating Factor,
pubmed-meshheading:9469353-Humans,
pubmed-meshheading:9469353-Ifosfamide,
pubmed-meshheading:9469353-Lung Neoplasms,
pubmed-meshheading:9469353-Male,
pubmed-meshheading:9469353-Middle Aged,
pubmed-meshheading:9469353-Prospective Studies,
pubmed-meshheading:9469353-Survival Rate,
pubmed-meshheading:9469353-Vincristine
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Effects of granulocyte-macrophage colony-stimulating factor and dose intensification of V-ICE chemotherapy in small-cell lung cancer: a prospective randomized study of 300 patients.
|
|
pubmed:affiliation |
Department of Oncology, Leicester Royal Infirmary, United Kingdom. william.steward@uni.romp.msmail.lri-tr.trent.nhs.uk
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Multicenter Study
|
